Healthcare - Medical - Devices - NASDAQ - US
$ 50.56
2.68 %
$ 2.96 B
Market Cap
-38.6
P/E
CASH FLOW STATEMENT
35.9 M
OPERATING CASH FLOW
-58 M
INVESTING CASH FLOW
1.17 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Inari Medical, Inc.
| Net Income | -1.64 M |
| Depreciation & Amortization | 10.7 M |
| Capital Expenditures | -6.2 M |
| Stock-Based Compensation | 40.3 M |
| Change in Working Capital | 2.64 M |
| Others | 5.21 M |
| Free Cash Flow | 29.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (1.6) | (29.3) | 9.8 | 13.8 | (1.2) | (10.2) |
| Depreciation & Amortization | 10.7 | 7.1 | 4.3 | 1.4 | 0.6 | 0.3 |
| Deferred Income Tax | (0.6) | 0 | 47 K | 4.2 | 1.3 | 0.1 |
| Stock Based Compensation | 40.3 | 28.7 | 25.4 | 3.5 | 0.5 | 0.2 |
| Other Operating Activities | (15.6) | 1.0 | 0.1 | 0.2 | 0.1 | 0.1 |
| Change in Working Capital | 2.6 | (21.5) | (14.3) | (21.2) | (6.3) | (1.5) |
| Cash From Operations | 35.9 | (14.0) | 25.5 | 1.9 | (4.9) | (10.9) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (6.2) | (10.0) | (13.6) | (5.5) | (3.1) | (0.8) |
| Other Items | (51.8) | (185.3) | (37.4) | (50.0) | 0 | 0 |
| Cash From Investing Activities | (58.0) | (195.2) | (51.0) | (55.4) | (3.1) | (0.8) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | (20.2) | 9.9 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (8.8) | (5.7) | (1.5) | 4 K | 0.4 | 26.8 |
| Cash From Financing Activities | 1.2 | 177.1 | 4.1 | 144.1 | 10.2 | 26.8 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (21.0) | (32.5) | (21.9) | 90.6 | 2.1 | 15.1 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | 29.7 | (23.9) | 11.8 | (3.5) | (8.1) | (11.6) |